Survival rates can range anywhere from 4 - 6 months or as long as a year
with additional chemotherapy treatments.
With surgery alone, most dogs survive 4 - 6 months, which can be increased to 10 - 12 months
with additional chemotherapy.
With additional chemotherapy a second remission is usually possible, though of shorter duration than the first.
Not exact matches
Even as he leads a national clinical trial testing a combination of paclitaxel
chemotherapy with an experimental agent known as efatutazone, Dr. Smallridge is working
with Dr. Copland and researcher Laura Marlow to find an HDAC inhibitor that might offer
additional benefit.
So
with an appropriate test, patients could avoid getting
additional radiation or
chemotherapy treatment they may not need, Dr. Shay said.
«We found very high response rates to this treatment combination, which has the added benefit of having a much reduced risk of long - term organ damage compared to the highly toxic
chemotherapy agents typically used for patients
with relapsed Hodgkin lymphoma,» says Dr. Kelly, who is Program Director of the Pediatric Hematology / Oncology Service Line at the Women & Children's Hospital of Buffalo and holds an
additional faculty appointment
with the University at Buffalo.
Specifically, they found that
chemotherapy alone leads to two types of dormant cancer cells that are not killed outright and become resistant to
additional chemotherapy, but when combined
with immunotherapy, a majority of dormant cells also is destroyed.
The period of time before ovarian cancer recurred (called progression - free survival) improved by nearly 3.5 months
with the
additional drug (13.8 months compared
with 10.4 months for the woman on
chemotherapy alone).
«Cumulative toxicity
with platinum - based
chemotherapy and lack of
additional benefit limits its use.
The identification of patients
with high - risk breast cancer is key to knowing whether a patient will require only the removal of the tumor by surgery or whether if she will need
additional chemotherapy to make sure the removal of breast cancer cells.
This translated into a median overall survival of 57.6 months for men who received early
chemotherapy compared
with 44 months in the group given ADT as the only initial treatment — more than a year of
additional life.
Researchers note that while PCI - aided delivery of
chemotherapy to the brain has proven effective in laboratory tests,
additional testing prior to human clinical trials is needed to identify other less - toxic blood - brain barrier agents to be used in tandem
with the photosensitizer in the PCI process.
Additional staging tests confirmed the diagnosis of B - cell lymphoma so treatment
with a multidrug
chemotherapy protocol was initiated.
Because of this, small cell lung cancer is treated
with chemotherapy,
with or without
additional radiotherapy.